Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 75 entries
View as:

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.

Phase: N/A Priority: Normal
NCT ID: NCT00036387 Org: User:
Start: - End: 11/30/03 Due: 11/30/04

A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00771667 Org: User:
Start: 12/31/08 End: 12/31/10 Due: 12/31/11

A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.

Phase: N/A Priority: Normal
NCT ID: NCT00269880 Org: User:
Start: 02/28/95 End: 12/31/95 Due: 12/31/96

A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00412321 Org: User:
Start: 05/31/05 End: 04/30/11 Due: 04/30/12

A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

Phase: N/A Priority: Normal
NCT ID: NCT00271401 Org: User:
Start: 07/31/96 End: 09/30/97 Due: 09/30/98

An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00264550 Org: User:
Start: 12/31/05 End: 05/31/12 Due: 05/31/13

First Study of the Safety of CNTO 888 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00537368 Org: User:
Start: 09/30/07 End: 03/31/10 Due: 03/31/11

A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00841191 Org: User:
Start: 03/31/09 End: 04/30/11 Due: 04/30/12

A Study of the Pharmacokinetics of Golimumab in Chinese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01288157 Org: User:
Start: 09/30/10 End: 01/31/11 Due: 01/31/12

A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00056264 Org: User:
Start: 12/31/02 End: 12/31/04 Due: 12/31/05

A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis

Phase: N/A Priority: Normal
NCT ID: NCT00955279 Org: User:
Start: 11/30/09 End: 08/31/12 Due: 08/31/13

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00207662 Org: User:
Start: 07/31/00 End: 11/30/05 Due: 11/30/06

A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00265122 Org: User:
Start: 04/30/04 End: 10/31/06 Due: 10/31/07

A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)

Phase: N/A Priority: Normal
NCT ID: NCT00299546 Org: User:
Start: 02/28/06 End: 05/31/12 Due: 05/31/13

A Study of the Pharmacokinetics of Ustekinumab in Chinese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01081704 Org: User:
Start: 10/31/09 End: 06/30/10 Due: 06/30/11

A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00361335 Org: User:
Start: 09/30/06 End: 09/30/09 Due: 09/30/10

A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00207675 Org: User:
Start: 02/28/03 End: 08/31/07 Due: 08/31/08

A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01258777 Org: User:
Start: 10/31/10 End: 04/30/11 Due: 04/30/12

A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)

Phase: N/A Priority: Normal
NCT ID: NCT00073372 Org: User:
Start: 10/31/03 End: 12/31/05 Due: 12/31/06

A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

Phase: N/A Priority: Normal
NCT ID: NCT00207701 Org: User:
Start: 09/30/02 End: 02/28/05 Due: 02/28/06

A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

Phase: N/A Priority: Normal
NCT ID: NCT00264537 Org: User:
Start: 12/31/05 End: 06/30/12 Due: 06/30/13

A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

Phase: N/A Priority: Normal
NCT ID: NCT00380796 Org: User:
Start: 04/30/06 End: 12/31/09 Due: 12/31/10

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00096655 Org: User:
Start: 05/31/02 End: 08/31/07 Due: 08/31/08

A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00207740 Org: User:
Start: 08/31/04 End: 07/31/07 Due: 07/31/08

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis

Phase: N/A Priority: Normal
NCT ID: NCT00076726 Org: User:
Start: 11/30/03 End: 07/31/05 Due: 07/31/06